ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,446, issued on Oct. 6, was assigned to BioVentures LLC.
"Use of simultaneous marker detection for assessing diffuse glioma and responsiveness to treatment" was invented by Analiz Rodriguez (Little Rock, Ark.) and Thidathip Wongsurawat (Little Rock, Ark.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a method to detect simultaneously mutations and methylation levels in a biological sample of a subject. In particular the present disclosure is directed to a method for diagnosing a central nervous system tumor such as a diffuse glioma, in a subject and comprises the steps of-determining at the same time the presence or a...